For some countries (Belgium, Croatia, Denmark, France, Malta, Netherlands, Norway and Türkiye) no data were available from the EWSD. The annual amounts used, in tablets, could be estimated for each survey participant based on their responses to questions on the number of tablets used on a typical day, multiplied by the number of days they said they used the drug in a year. As such, only last year prevalence and last month prevalence data are required to distinguish these two groups. Prevalence rates of the number of MDMA users, obtained from general population surveys, are multiplied by 2021 Eurostat population data of the age group. Wastewater data also reflect the predominant use of ecstasy in recreational settings, with more than three quarters of cities reporting that higher loads of MDMA were present in wastewater during the weekend than during weekdays in 2022. While the number of tablets used per session has not changed substantially from literature findings dating from several decades ago, today’s MDMA users generally ingest higher quantities of the psychoactive substance than before (Gremeaux, 2022

The subsequent drop in MDMA content in tablets since 2019 does not appear to have been accompanied by a significant drop in price. In 2021, adult respondents to the EWSD reported paying a median of EUR 7.20 per ecstasy tablet and a median of EUR 37.40 per gram for MDMA powder. (a) In clinical trials, doses of MDMA capable of producing subjective effects vary from 1.5 to 1.7 mg/kg of body weight, or approximately 105 to 119 milligrams for a 70-kilogram individual. Harm reduction responses, including the provision of drug-checking services and appropriate risk-communication strategies, are crucial to minimise these risks. Some tablets even contain stamping that indicate the quantity of MDMA present, although this is not always accurate and may also constitute a health risk. For example, in August 2023, tablets containing 350 milligrams of MDMA were seized in Spain.


Some of the price disparity may be attributed to local factors, including distance to the producing centres (Netherlands and Belgium), but statistical artefacts (e.g. small sample sizes) may also be a factor. Individual factors and sex affect this dose, with women considered to be more susceptible to the 5-HT-releasing effects of MDMA (Liechti et al., 2001). Harm reduction responses, including the provision of drug-checking services and appropriate risk-communication strategies, are crucial to minimise these risks. This is consistent with law enforcement information that suggests the MDMA market in Europe is supplied by the same pool of producers, mostly based in the Netherlands and Belgium. It should be noted that this trend was observed across several countries in Europ

Surrey Young People’s Substance Use Service
In these cases, the missing information was replaced with the mean, computed on the remaining countries. In calculating the amounts used, it was assumed that the maximum realistic amount to use in a day was five tablets; mdma for sale online those reporting higher values were excluded. The amount of MDMA used annually by these two different user groups was estimated using data from the EWSD. Cannabis, alcohol and to a lesser extent cocaine, amphetamine, methamphetamine, ketamine and GHB are consumed in combination with MDMA. Graphics showing the most recent data for a country are based on studies carried out between 2013 and 2023. Prevalence data presented here are based on general population surveys submitted to the EMCDDA by national focal points.


Based on reporting from drug-checking clients, the majority of samples were reported as being obtained from a supplier (either a trusted supplier or a random street supplier) and a smaller proportion (close to 5 %) as bought on the internet (surface web or darknet). For example, 79 % of the Polish respondents reported mostly buying the drug, compared to 51 % of the respondents from Luxembourg. For example, alcoholic drinks containing MDMA are submitted for drug checking from time to tim


It typically appears on drug tests as MDMA or sometimes under its street names, Ecstasy or Molly. MDMA stands for 3,4-methylenedioxymethamphetamine, a synthetic drug known for its stimulant and psychedelic properties. Neurologically speaking, Ecstasy tickles all the right spots of your brain. Despite being the world’s most popular entactogen, MDMA remains a Schedule I drug under the DEA’s classification due to its high potential for abuse and lack of recognized medical use. Always consult a health care professional before making a decision about your medication or treatment.
Why Does My Tracking Info Still Say "Label Created, Not yet in the System" When I Placed It X Days Ag


This is because ecstasy tablets now contain more MDMA, on average, than they did in the past (see Section Price and purity). Information gathered in the 2021 EWSD suggests that, on average, those who reported having used MDMA in the last 12 months, consumed one ecstasy tablet or 0.4 grams of MDMA in crystal or powders form each time they used the drug. All of the 10 cities with data for both 2011 and 2023 had higher MDMA levels in 2023 than in 2011 (see Figure 6.6. Key prevalence data for MDMA/ecstasy use in Europe). Where prevalence is higher, it may suggest that MDMA is no longer a niche or subcultural drug limited to dance clubs and parties in those markets.
Harms and ris